The mood stabilizer valproate activates human FGF1 gene promoter through inhibiting HDAC and GSK-3 activities

Journal of Neurochemistry

Volumn 126, Issue 1, 2013, Pages 4-18

  Kao, Chien Yu ^a,b   Hsu, Yi Chao ^a,d   Liu, Jen Wei ^a,c   Lee, Don Ching ^a   Chung, Yu Fen ^a   Chiu, Ing Ming ^a,b,c  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^d MACKAY MEDICAL COLLEGE   (Taiwan)

Author keywords

FGF1; GSK 3; HDACs; lithium; RFX; VPA

Indexed keywords

BUTYRIC ACID; GLYCOGEN SYNTHASE KINASE 3; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; LITHIUM; MESSENGER RNA; REGULATOR PROTEIN; REGULATORY FACTOR X; TRICHOSTATIN A; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL CELL; ARTICLE; ASCL GENE; BRN2 GENE; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; FGF 1B GENE; FLOW CYTOMETRY; GENE; GENE ACTIVATION; GENE EXPRESSION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; MOUSE; MYT1L GENE; NERVE CELL DIFFERENTIATION; NEUROD1 GENE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; RFX2 GENE; RFX3 GENE;

ANIMALS; ANTIMANIC AGENTS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EMBRYONIC STEM CELLS; FIBROBLAST GROWTH FACTOR 1; FLOW CYTOMETRY; GLYCOGEN SYNTHASE KINASE 3; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; IMMUNOHISTOCHEMISTRY; LITHIUM CHLORIDE; MICE; NEURAL STEM CELLS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; RNA, SMALL INTERFERING; TRANSCRIPTIONAL ACTIVATION; VALPROIC ACID;

EID: 84879410872     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12292     Document Type: Article

References (64)

1. Abel T., and, Zukin R. S., (2008) Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr. Opin. Pharmacol. 8, 57-64.
2. Aubry J. M., Schwald M., Ballmann E., and, Karege F., (2009) Early effects of mood stabilizers on the Akt/GSK-3beta signaling pathway and on cell survival and proliferation. Psychopharmacology 205, 419-429.
3. Beenken A., and, Mohammadi M., (2009) The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discovery 8, 235-253.
4. Chen G., Huang L. D., Jiang Y. M., and, Manji H. K., (1999) The Mood-Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase-3. J. Neurochem. 72, 1327-1330.
5. Chen C. W., Liu C. S., Chiu I. M., Shen S. C., Pan H. C., Lee K. H., Lin S. Z., and, Su H. L., (2010a) The signals of FGFs on the neurogenesis of embryonic stem cells. J. Biomed. Sci. 17, 33.
6. Chen Y. C., Lee D. C., Tsai T. Y., et al,. (2010b) Induction and regulation of differentiation in neural stem cells on ultra-nanocrystalline diamond films. Biomaterials 31, 5575-5587.
7. Chiu I. M., Touhalisky K., Liu Y., Yates A., and, Frostholm A., (2000) Tumorigenesis in transgenic mice in which the SV40 T antigen is driven by the brain-specific FGF1 promoter. Oncogene 19, 6229-6239.
8. Chiu I. M., Touhalisky K., and, Baran C., (2001) Multiple controlling mechanisms of FGF1 gene expression through multiple tissue-specific promoters. Prog. Nucleic Acid Res. Mol. Biol. 70, 155-174.
9. Chotani M. A., Touhalisky K., and, Chiu M., (2000) The small GTPases Ras, Rac, and Cdc42 transcriptionally regulate expression of human fibroblast growth factor 1. J. Biol. Chem. 275, 30432-30438.
10. Chuang D. M., Leng Y., Marinova Z., Kim H. J., and, Chiu C. T., (2009) Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci. 32, 591-601.
11. De Sarno P., Li X., and, Jope R. S., (2002) Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 43, 1158-1164.
12. Evans S., Choudary P., Neal C., et al,. (2004) Dysregulation of the fibroblast growth factor system in major depression. Proc. Natl Acad. Sci. USA 101, 15506-15511.
13. Fischer A., Sananbenesi F., Wang X., Dobbin M., and, Tsai L. H., (2007) Recovery of learning and memory is associated with chromatin remodelling. Nature 447, 178-182.
14. Galli R., Binda E., Orfanelli U., et al,. (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64, 7011-7021.
15. Gaspard N., Bouschet T., Herpoel A., Naeije G., van den Ameele J., and, Vanderhaeghen P., (2009) Generation of cortical neurons from mouse embryonic stem cells. Nat. Protoc. 4, 1454-1463.
16. Gottlicher M., Minucci S., Zhu P., et al,. (2001) Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 20, 6969-6978.
17. Hao Y., Creson T., Zhang L., Li P., Du F., Yuan P., Gould T. D., Manji H. K., and, Chen G., (2004) Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J. Neurosci. 24, 6590-6599.
18. Harrison M. R. M., Georgiou A. S., Spaink H. P., and, Cunliffe V. T., (2011) The epigenetic regulator Histone Deacetylase 1 promotes transcription of a core neurogenic programme in zebrafish embryos. BMC Genomics 12, 24.
19. Higashi M., Maruta N., Bernstein A., Ikenaka K., and, Hitoshi S., (2008) Mood stabilizing drugs expand the neural stem cell pool in the adult brain through activation of notch signaling. Stem Cells 26, 1758-1767.
20. Hsieh J., Nakashima K., Kuwabara T., Mejia E., and, Gage F. H., (2004) Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc. Natl Acad. Sci. USA 101, 16659-16664.
21. Hsu Y. C., Lee D. C., Chen S. L., Liao W. C., Lin J. W., Chiu W. T., and, Chiu I. M., (2009) Brain-specific 1B promoter of FGF1 gene facilitates the isolation of neural stem/progenitor cells with self-renewal and multipotent capacities. Dev. Dyn. 238, 302-314.
22. Hsu Y. C., Liao W. C., Kao C. Y., and, Chiu I. M., (2010) Regulation of FGF1 gene promoter through transcription factor RFX1. J. Biol. Chem. 285, 13885-13895.
23. Hsu Y. C., Kao C. Y., Chung Y. F., Chen M. S., and, Chiu I. M., (2012) Ciliogenic RFX transcription factors regulate FGF1 gene promoter. J. Cell. Biochem. 113, 2511-2522.
24. Hur E. M., and, Zhou F. Q., (2010) GSK3 signalling in neural development. Nat. Rev. Neurosci. 11, 539-551.
25. Jin N., Kovacs A. D., Sui Z., Dewhurst S., and, Maggirwar S. B., (2005) Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death. Neuropharmacology 48, 576-583.
26. Jonker J. W., Suh J. M., Atkins A. R., et al,. (2012) A PPARgamma-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis. Nature 485, 391-394.
27. Juliandi B., Abematsu M., Sanosaka T., Tsujimura K., Smith A., and, Nakashima K., (2012) Induction of superficial cortical layer neurons from mouse embryonic stem cells by valproic acid. Neurosci. Res. 72, 23-31.
28. Jungerius B., Hoogendoorn M., Bakker S., Van't Slot R., Bardoel A., Ophoff R., Wijmenga C., Kahn R., and, Sinke R., (2007) An association screen of myelin-related genes implicates the chromosome 22q11 PIK4CA gene in schizophrenia. Mol. Psychiatry 13, 1060-1068.
29. Kazantsev A. G., and, Thompson L. M., (2008) Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat. Rev. Drug Discovery 7, 854-868.
30. Kim H. J., Rowe M., Ren M., Hong J. S., Chen P. S., and, Chuang D. M., (2007) Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J. Pharmacol. Exp. Ther. 321, 892-901.
31. Kim H. J., Leeds P., and, Chuang D. M., (2009) The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain. J. Neurochem. 110, 1226-1240.
32. Kozlovsky N., Amar S., Belmaker R. H., and, Agam G., (2006) Psychotropic drugs affect Ser9-phosphorylated GSK-3 beta protein levels in rodent frontal cortex. Int. J. Neuropsychopharmacol. 9, 337-342.
33. Lee D. C., Hsu Y. C., Chung Y. F., Hsiao C. Y., Chen S. L., Chen M. S., Lin H. K., and, Chiu I. M., (2009) Isolation of neural stem/progenitor cells by using EGF/FGF1 and FGF1B promoter-driven green fluorescence from embryonic and adult mouse brains. Mol. Cell. Neurosci. 41, 348-363.
34. Leng Y., Liang M. H., Ren M., Marinova Z., Leeds P., and, Chuang D. M., (2008) Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition. J. Neurosci. 28, 2576-2588.
35. Li X., Frye M. A., and, Shelton R. C., (2012) Review of pharmacological treatment in mood disorders and future directions for drug development. Neuropsychopharmacology 37, 77-101.
36. Lin W. F., Chen C. J., Chang Y. J., Chen S. L., Chiu I. M., and, Chen L., (2009) SH2B1beta enhances fibroblast growth factor 1 (FGF1)-induced neurite outgrowth through MEK-ERK1/2-STAT3-Egr1 pathway. Cell. Signal. 21, 1060-1072.
37. Ma D. K., Jang M. H., Guo J. U., et al,. (2009) Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science 323, 1074-1077.
38. Ma D. K., Marchetto M. C., Guo J. U., Ming G., Gage F. H., and, Song H., (2010) Epigenetic choreographers of neurogenesis in the adult mammalian brain. Nat. Neurosci. 13, 1338-1344.
39. Maragnoli M. E., Fumagalli F., Gennarelli M., Racagni G., and, Riva M. A., (2004) Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain. Biol. Psychiatry 55, 1095-1102.
40. Mason I., (2007) Initiation to end point: the multiple roles of fibroblast growth factors in neural development. Nat. Rev. Neurosci. 8, 583-596.
41. McDermott K. L., Raghupathi R., Fernandez S. C., Saatman K. E., Protter A. A., Finklestein S. P., Sinson G., Smith D. H., and, McIntosh T. K., (1997) Delayed administration of basic fibroblast growth factor (bFGF) attenuates cognitive dysfunction following parasagittal fluid percussion brain injury in the rat. J. Neurotrauma 14, 191-200.
42. Montgomery R. L., Hsieh J., Barbosa A. C., Richardson J. A., and, Olson E. N., (2009) Histone deacetylases 1 and 2 control the progression of neural precursors to neurons during brain development. Proc. Natl Acad. Sci. 106, 7876-7881.
43. Myers R., Payson R., Chotani M., Deaven L., and, Chiu I., (1993) Gene structure and differential expression of acidic fibroblast growth factor mRNA: identification and distribution of four different transcripts. Oncogene 8, 341.
44. Myers R. L., Chedid M., Tronick S. R., and, Chiu I. M., (1995) Different fibroblast growth factor 1 (FGF-1) transcripts in neural tissues, glioblastomas and kidney carcinoma cell lines. Oncogene 11, 785-789.
45. Ohkubo Y., Uchida A. O., Shin D., Partanen J., and, Vaccarino F. M., (2004) Fibroblast growth factor receptor 1 is required for the proliferation of hippocampal progenitor cells and for hippocampal growth in mouse. J. Neurosci. 24, 6057-6069.
46. Pang Z. P., Yang N., Vierbuchen T., et al,. (2011) Induction of human neuronal cells by defined transcription factors. Nature 476, 220-223.
47. Pfenninger C. V., Roschupkina T., Hertwig F., Kottwitz D., Englund E., Bengzon J., Jacobsen S. E., and, Nuber U. A., (2007) CD133 is not present on neurogenic astrocytes in the adult subventricular zone, but on embryonic neural stem cells, ependymal cells, and glioblastoma cells. Cancer Res. 67, 5727-5736.
48. Phiel C. J., Zhang F., Huang E. Y., Guenther M. G., Lazar M. A., and, Klein P. S., (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276, 36734-36741.
49. Polter A., Beurel E., Yang S., et al,. (2010) Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances. Neuropsychopharmacology 35, 1761-1774.
50. Pruszak J., Ludwig W., Blak A., Alavian K., and, Isacson O., (2009) CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells. Stem Cells 27, 2928-2940.
51. Ray S., Yang X., and, Chiu I., (1997) Transcriptional activation of fibroblast growth factor 1. B promoter is mediated through an 18-base pair cis-acting element. J. Biol. Chem. 272, 7546.
52. Stambolic V., Ruel L., and, Woodgett J. R., (1996) Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol. 6, 1664-1669.
53. Sun J., Ming G., and, Song H., (2011) Epigenetic regulation of neurogenesis in the adult mammalian brain. Eur. J. Neurosci. 33, 1087-1093.
54. Thisse B., and, Thisse C., (2005) Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev. Biol. 287, 390-402.
55. Turner C. A., Gula E. L., Taylor L. P., Watson S. J., and, Akil H., (2008) Antidepressant-like effects of intracerebroventricular FGF2 in rats. Brain Res. 1224, 63-68.
56. Turner C. A., Watson S. J., and, Akil H., (2012) The fibroblast growth factor family: neuromodulation of affective behavior. Neuron 76, 160-174.
57. Valoušková V., and, Gschanes A., (1999) Effects of NGF, b-FGF, and cerebrolysin on water maze performance and on motor activity of rats: short-and long-term study. Neurobiol. Learn. Mem. 71, 132-149.
58. Wada A., (2009) Lithium and Neuropsychiatric Therapeutics: Neuroplasticity via Glycogen Synthase Kinase-3. BETA., BETA.-Catenin, and Neurotrophin Cascades. J. Pharmacol. Sci. 110, 14-28.
59. Werstuck G. H., Kim A. J., Brenstrum T., Ohnmacht S. A., Panna E., and, Capretta A., (2004) Examining the correlations between GSK-3 inhibitory properties and anti-convulsant efficacy of valproate and valproate-related compounds. Bioorg. Med. Chem. Lett. 14, 5465-5467.
60. Xu Y., Sengupta P. K., Seto E., and, Smith B. D., (2006) Regulatory factor for X-box family proteins differentially interact with histone deacetylases to repress collagen alpha2(I) gene (COL1A2) expression. J. Biol. Chem. 281, 9260-9270.
61. Yasuda S., Liang M., Marinova Z., Yahyavi A., and, Chuang D., (2007) The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol. Psychiatry 14, 51-59.
62. Yu I. T., Park J. Y., Kim S. H., Lee J., Kim Y. S., and, Son H., (2009) Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation. Neuropharmacology 56, 473-480.
63. Zakrzewska M., Marcinkowska E., and, Wiedlocha A., (2008) FGF-1: from biology through engineering to potential medical applications. Crit. Rev. Clin. Lab. Sci. 45, 91-135.
64. Zhang F., Phiel C. J., Spece L., Gurvich N., and, Klein P. S., (2003) Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. J. Biol. Chem. 278, 33067-33077.